XML 62 R51.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF WARRANTS OUTSTANDING (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Intrinsic Value, Outstanding $ 801,024 $ 8,923,797
Exchanged for common stock   (15,363)
Intrinsic Value, Outstanding $ 5,514 $ 801,024
Warrant [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Warrant shares outstanding at beginning 195,463 74,617
Weighted average exercise Price, Outstanding at beginning $ 131.00 $ 102.50
Sharebased compensation arrangement by sharebased payment award nonoption equity instruments outstanding weighted average remaining contractual term beginning 3 years 4 months 24 days 5 years 2 months 12 days
Warrant shares outstanding, issued 1,227,500 82,923
Weighted average exercise price, issued $ 10.31 $ 210.00
Warrant shares outstanding, Assumed pursuant to acquisition of Magic Med   118,274
Weighted average exercise price, Assumed pursuant to acquisition of Magic Med   $ 65.50
Warrant shares outstanding, Exercised (767,500) (64,988)
Weighted average exercise price, Exercised   $ 50.50
Weighted average exercise price, Exchanged for common stock   $ 232.50
Warrant shares outstanding at end 655,463 195,463
Weighted average exercise price, Outstanding at end $ 58.36 $ 131.00
Sharebased compensation arrangement by sharebased payment award non option equity instruments outstanding weighted average remaining contractual term ending 3 years 7 months 6 days  
Warrant shares outstanding, exercisable 655,463  
Weighted average exercise price, exercisable $ 58.36  
Weighted average remaining life, exercisable 3 years 7 months 6 days  
Intrinsic value, exercisable $ 5,514